ArticleFrontiers in medicine2026
Reflux esophagitis patients exhibit reduced gastric tolerance, impaired slow-wave activity and esophageal dysmotility.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Reflux esophagitis (RE) is an endoscopic subtype of gastroesophageal reflux disease (GERD). Although gastric dysfunction is known to contribute to GERD, a comprehensive assessment of gastric motor function specifically in RE patients remains lacking. Objective: To comprehensively evaluate gastric motor function in patients with reflux esophagitis (RE) using a multidimensional non-invasive protocol, and to explore the associations between gastric motility abnormalities and esophageal dysmotility. Methods: Forty RE patients diagnosed by endoscopy and high-resolution manometry (HRM) and 34 healthy controls were enrolled between April 2019 and January 2020 based on feasibility of recruitment during the study period. Gastric tolerance and visceral sensitivity were evaluated using a nutrient drink test combined with a visual analog scale (VAS). Gastric emptying was assessed by gastrointestinal ultrasound, and gastric myoelectrical activity was recorded by electrogastrography (EGG). Esophageal motility was simultaneously evaluated by HRM. Results: Compared with controls, RE patients showed significantly reduced maximum tolerated volume (MTV), higher postprandial VAS scores for fullness, nausea and pain, lower gastric emptying rates at 20 and 30 min postprandially, and a lower percentage of normal postprandial slow waves (all Conclusion: RE patients exhibit multiple gastric motility abnormalities, including reduced gastric tolerance, visceral hypersensitivity, delayed gastric emptying, and postprandial gastric dysrhythmia. These gastric dysfunctions are associated with typical RE symptoms and selectively correlate with esophageal contractile indices, suggesting that RE may represent a disorder of upper gastrointestinal motility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.